D-Sight — Seed · €2M

D-Sight, a clinical-stage spin-off of the Vall d'Hebron Research Institute, raised €2M led by its main investor Clave Capital, with Prous Institute for Biomedical Research, Institut Català de Finances and BioAngels Club participating; it complements €1.5M of public CPP 2024 funding. El Referente counted the deal in its February 2026 tally but the exact announcement day was not stated in the sources found.